This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics


  • 00
  • 00
  • 00
  • 00
Delivered as Hybrid Event from 16-18 November 2022
Live In-Person Conference Delivered 16-18 NovemberAustria Center Vienna

Andreas Wagner
Head of Liposome Technology at Polymun Scientific GmbH


Dr Andreas Wagner is currently the Head, Liposome Technology at Polymun Scientific GmbH. He has significant expertise in incorporation and optimization of hydrophilic, lipophilic and amphipatic substances into liposomes and LNPs and development for clinical use. He studied Biotechnology in Vienna, Austria and earned his Master and Ph.D. degrees in the field of biopharmaceutical technology/ liposomology at the Institute of Applied Microbiology supervised by Prof. Hermann Katinger. Dr Andreas Wagner is listed as inventor on several patents, like the liposome technology and some product patents of liposomal formulations. Furthermore, he has published several peer reviewed articles dealing with liposomes, the technology, products thereof and their application in preclinical and clinical studies.

Polymun Scientific GmbH

is a private Austrian company, located in Klosterneuburg, offering contract development and manufacturing of biopharmaceuticals as well as development and production of liposomal formulations. Its patented liposome technology allows efficient manufacturing of constantly high quality in small and large scale. Polymun is an EMEA-certified manufacturer conducting several own R&D projects. For more information, please visit

Agenda Sessions

  • Guiding mRNA-LNP Drug Products from Early R&D Programs to the Market – Scale Up and Production of mRNA LNPs


Speakers at this event